M
Magenta Medical
Magenta Medical has developed a temporary venous catheter-based therapy
About Magenta Medical
Magenta Medical develops advanced medical devices focused on providing temporary support for patients with severe heart conditions. The company specializes in two main products: the percutaneous Left Ventricular Assist Device (pLVAD) and the Transcatheter Renal Venous Decongestion System. The pLVAD is a next-generation, low-profile arterial pump designed to offer temporary support for patients undergoing high-risk coronary interventions and those suffering from cardiogenic shock. The Transcatheter Renal Venous Decongestion System is a venous pump aimed at treating hospitalized patients with acutely decompensated heart failure by reducing renal venous pressure and decompressing the kidneys.
Magenta Medical primarily serves hospitals and healthcare providers dealing with critical heart failure cases. Operating in the medical device market, the company employs a business model that includes the development, manufacturing, and sale of its specialized pumps. Revenue is generated through direct sales to healthcare institutions and partnerships with medical distributors.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 118
- Open positions
- 7
- Dealroom signal
- 54.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Surgery, Cardiology and cardiovascular, Surgical Equipment, Tech for Hospitals and Clinics, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- B2B
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jul 2024 | $105M | $420M | NEA · OrbiMed · Viking Global Investors · JVC Investment Partners | ↗ |
| LATE VCOther financing | May 2023 | $55M | $220M | Pitango Venture Capital · NEA · ALIVE Israel HealthTech Fund · OrbiMed | ↗ |
Growth signals
Latest recorded traffic for Magenta Medical is 3.2K monthly website visits, up 332.4% over the last three months. Magenta Medical's team grew 11.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Magenta Medical in the Tel Aviv-Yafo ecosystem
The Magenta Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A3 investors entered at this stage
Abiomed
ABIOMED, LTD.
Jacques R. Seguin
Series B and later7 investors entered at this stage
NEA
ALIVE Israel HealthTech Fund
OrbiMed
Novo Holdings
Viking Global Investors- JPJVC Investment Partners
RA Capital Management
Source: Dealroom Talent Intelligence.
See Magenta Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










